ID   BALM-26
AC   CVCL_5702
DR   JCRB; JCRB1803
DR   Wikidata; Q54753200
RX   PubMed=12703546;
CC   Population: Japanese.
CC   Doubling time: 35 hours (PubMed=12703546).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1803
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5695 ! BALM-19
OI   CVCL_5697 ! BALM-20
OI   CVCL_5698 ! BALM-21
OI   CVCL_5699 ! BALM-22
OI   CVCL_5700 ! BALM-23
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
RX   PubMed=12703546; DOI=10.1111/j.1749-0774.2002.tb00110.x;
RA   Matsuo, Yoshinobu
RA   Drexler, Hans Gunther
RA   Kojima, Kensuke
RA   Sugimoto, Akira
RA   Harashima, Akira
RA   Okochi, Ayumi
RA   Hara, Masamichi
RA   Orita, Kunzo
RT   "Novel B-cell acute lymphoblastic leukemia sister cell lines BALM 19-23
RT   and BALM-26 with interclonal proliferative and phenotypic heterogeneity
RT   from a patient with hypercalcemia.";
RL   Hum. Cell 15:160-170(2002).
//